Simon R Mucha
Overview
Explore the profile of Simon R Mucha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh A, Mucha S, Lindenmeyer C
Cleve Clin J Med
. 2023 Nov;
89(9):523-533.
PMID: 37907441
Cirrhosis has been regarded as a hypocoagulable state associated with an increased risk of bleeding. But patients with cirrhosis also have a high incidence of thrombotic complications, challenging this dogma....
2.
Mucha S, Rajendram P
Curr Oncol
. 2023 May;
30(5):5003-5023.
PMID: 37232836
Chimeric Antigen Receptor T (CAR-T) cell therapy has dramatically changed prognosis and treatment of relapsed and refractory hematologic malignancies. Currently the 6 FDA approved products target various surface antigens. While...
3.
Mucha S, Dugar S, McCrae K, Joseph D, Bartholomew J, Sacha G, et al.
Cleve Clin J Med
. 2020 Dec;
PMID: 33323363
Severe COVID-19 illness is associated with intense inflammation, leading to high rates of thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are...
4.
Mucha S, Dugar S, McCrae K, Joseph D, Bartholomew J, Sacha G, et al.
Cleve Clin J Med
. 2020 Nov;
87(12):712.
PMID: 33229381
No abstract available.
5.
Mucha S, Quraishy N
Cleve Clin J Med
. 2020 Aug;
87(11):664-670.
PMID: 32759176
While promising, convalescent plasma remains experimental and is not proven effective for COVID-19. In addition, many questions remain regarding the accuracy and predictive value of antibody testing of donors and...
6.
Mucha S, Dugar S, McCrae K, Joseph D, Bartholomew J, Sacha G, et al.
Cleve Clin J Med
. 2020 May;
87(8):461-468.
PMID: 32409435
Severe COVID-19 illness is associated with intense inflammation, leading to high rates of thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are...
7.
De Toni E, Kuntzen C, Gerbes A, Thasler W, Sonuc N, Mucha S, et al.
J Hepatol
. 2007 Jan;
46(4):682-91.
PMID: 17224200
Background/aims: Failure to induce apoptosis triggered by members of the death receptor family has been described in hepatocellular carcinoma (HCC) and sensitization of malignant cells to pro-apoptotic molecules such as...
8.
Kuntzen C, Sonuc N, De Toni E, Opelz C, Mucha S, Gerbes A, et al.
Cancer Res
. 2005 Aug;
65(15):6780-8.
PMID: 16061660
Loss of susceptibility to apoptosis signals is a crucial step in carcinogenesis. Therefore, sensitization of tumor cells to apoptosis is a promising therapeutic strategy. c-Jun-N-terminal-kinases (JNK) have been implicated in...